Site-specific effects of neurosteroids on GABA.sub.A receptor activation and desensitization

• Published in: eLife Vol. 9
• Main Authors: Sugasawa, Yusuke, Cheng, Wayland W.L, Bracamontes, John R, Chen, Zi-Wei, Wang, Lei, Germann, Allison L, Pierce, Spencer R, Senneff, Thomas C, Krishnan, Kathiresan, Reichert, David E, Covey, Douglas F, Akk, Gustav, Evers, Alex S
• Format: Journal Article
• Language: English
• Published: eLife Science Publications, Ltd 21-09-2020
• Subjects: Adrenocortical hormones; Analysis; Binding sites (Biochemistry); Control; GABA receptors; Physiological aspects
• ISSN: 2050-084X; 2050-084X
• DOI: 10.7554/eLife.55331

This study examines how site-specific binding to three identified neurosteroid-binding sites in the [alpha].sub.1[beta].sub.3 GABA.sub.A receptor (GABA.sub.AR) contributes to neurosteroid allosteric modulation. We found that the potentiating neurosteroid, allopregnanolone, but not its inhibitory 3[beta]-epimer epi-allopregnanolone, binds to the canonical [beta].sub.3(+)--[alpha].sub.1(-) intersubunit site that mediates receptor activation by neurosteroids. In contrast, both allopregnanolone and epi-allopregnanolone bind to intrasubunit sites in the [beta].sub.3 subunit, promoting receptor desensitization and the [alpha].sub.1 subunit promoting effects that vary between neurosteroids. Two neurosteroid analogues with diazirine moieties replacing the 3-hydroxyl (KK148 and KK150) bind to all three sites, but do not potentiate GABA.sub.AR currents. KK148 is a desensitizing agent, whereas KK150 is devoid of allosteric activity. These compounds provide potential chemical scaffolds for neurosteroid antagonists. Collectively, these data show that differential occupancy and efficacy at three discrete neurosteroid-binding sites determine whether a neurosteroid has potentiating, inhibitory, or competitive antagonist activity on GABA.sub.ARs.